BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7996637)

  • 1. From the Centers for Disease Control and Prevention. Erythromycin-resistant Bordetella pertussis--Yuma County, Arizona, May-October 1994.
    JAMA; 1995 Jan; 273(1):13-4. PubMed ID: 7996637
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythromycin-resistant Bordetella pertussis--Yuma County, Arizona, May-October 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Nov; 43(44):807-10. PubMed ID: 7968996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis.
    Lewis K; Saubolle MA; Tenover FC; Rudinsky MF; Barbour SD; Cherry JD
    Pediatr Infect Dis J; 1995 May; 14(5):388-91. PubMed ID: 7638015
    [No Abstract]   [Full Text] [Related]  

  • 4. Bordetella pertussis isolates with a heterogeneous phenotype for erythromycin resistance.
    Wilson KE; Cassiday PK; Popovic T; Sanden GN
    J Clin Microbiol; 2002 Aug; 40(8):2942-4. PubMed ID: 12149356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of erythromycin-resistant Bordetella pertussis in Xi'an, China.
    Wang Z; Cui Z; Li Y; Hou T; Liu X; Xi Y; Liu Y; Li H; He Q
    Clin Microbiol Infect; 2014 Nov; 20(11):O825-30. PubMed ID: 24816168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of fluoroquinolones against erythromycin-susceptible and -resistant Bordetella pertussis.
    Bourgeois N; Ghnassia JC; Doucet-Populaire F
    J Antimicrob Chemother; 2003 Mar; 51(3):742-3. PubMed ID: 12615884
    [No Abstract]   [Full Text] [Related]  

  • 7. High-resolution melting analysis for the detection of two erythromycin-resistant Bordetella pertussis strains carried by healthy schoolchildren in China.
    Zhang Q; Li M; Wang L; Xin T; He Q
    Clin Microbiol Infect; 2013 Jun; 19(6):E260-2. PubMed ID: 23480481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility testing of Bordetella pertussis in Taiwan prompted by a case of pertussis in a paediatric patient.
    Yao SM; Liaw GJ; Chen YY; Yen MH; Chen YH; Mu JJ; Chiang CS
    J Med Microbiol; 2008 Dec; 57(Pt 12):1577-1580. PubMed ID: 19018032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythromycin for pertussis: probable reasons for past failures.
    Bass JW
    Lancet; 1985 Jul; 2(8447):147. PubMed ID: 2862331
    [No Abstract]   [Full Text] [Related]  

  • 10. Where macrolide resistance is prevalent.
    Li Y; Liu X; Zhang B; He Q; Wang Z
    APMIS; 2015 Apr; 123(4):361-3. PubMed ID: 25703275
    [No Abstract]   [Full Text] [Related]  

  • 11. Genomic epidemiology of erythromycin-resistant Bordetella pertussis in China.
    Xu Z; Wang Z; Luan Y; Li Y; Liu X; Peng X; Octavia S; Payne M; Lan R
    Emerg Microbes Infect; 2019; 8(1):461-470. PubMed ID: 30898080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bordetella pertussis: a case of whooping cough in a newborn].
    Ben Hassine A; Bejaoui M; Lakhoua M; Ben Redjeb S
    Tunis Med; 1994 Dec; 72(12):719-22. PubMed ID: 7624981
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevalence of pertussis in Fukuoka: incidence and MICs of antibiotics for Bordetella pertussis isolate].
    Horikawa K; Okada K; Ishibashi T; Murakami K; Ohbuchi N; Ueda K
    Kansenshogaku Zasshi; 1995 Aug; 69(8):878-83. PubMed ID: 7594779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance of antimicrobial resistance in contemporary clinical isolates of Bordetella pertussis in Ontario, Canada.
    Marchand-Austin A; Memari N; Patel SN; Tang P; Deeks SL; Jamieson FB; Crowcroft NS; Farrell DJ
    Int J Antimicrob Agents; 2014 Jul; 44(1):82-4. PubMed ID: 24837412
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimicrobial susceptibility testing of clinical isolates of Bordetella pertussis from northern California: report from the SENTRY Antimicrobial Surveillance Program.
    Gordon KA; Fusco J; Biedenbach DJ; Pfaller MA; Jones RN
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3599-600. PubMed ID: 11709347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimum inhibitory concentrations of erythromycin and other antibiotics for Czech strains of Bordetella pertussis.
    Jakubů V; Zavadilová J; Fabiánová K; Urbášková P
    Epidemiol Mikrobiol Imunol; 2015 Mar; 64(1):12-5. PubMed ID: 25872990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemic of erythromycin-resistant
    Yao K; Deng J; Ma X; Dai W; Chen Q; Zhou K; Ye J; Shi W; Wang H; Li D; Wang H; Wang J; Zhang J; Wu D; Xie G; Shen K; Zheng Y; Yang Y
    Expert Rev Vaccines; 2020 Nov; 19(11):1093-1099. PubMed ID: 33034224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive respiratory distress in an infant treated for presumed pertussis.
    Lee B
    Pediatr Infect Dis J; 2000 May; 19(5):475, 492-3. PubMed ID: 10819348
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythromycin for treatment and prevention of pertussis.
    Bass JW
    Pediatr Infect Dis; 1986; 5(1):154-7. PubMed ID: 2868449
    [No Abstract]   [Full Text] [Related]  

  • 20. Co-infection with two different strains of Bordetella pertussis in an infant.
    Cassiday PK; Tobin-D'Angelo M; Watson JR; Wu KH; Park MM; Sanden GN
    J Med Microbiol; 2008 Mar; 57(Pt 3):388-391. PubMed ID: 18287306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.